We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Interleukin‐23 inhibitors demonstrate high effectiveness in the treatment of a real‐world cohort of 82 psoriatic patients regardless of the HLA‐Cw6 status.
- Authors
Rubio‐Muniz, Carmen Alejandra; Lopez‐Valle, Alba; Agud‐Dios, Manuel; Arroyo‐Andres, Jorge; Rivera‐Díaz, Raquel
- Abstract
HLA-Cw6-positive patients with psoriasis show improved response to methotrexate treatment. Interleukin-23 inhibitors demonstrate high effectiveness in the treatment of a real-world cohort of 82 psoriatic patients regardless of the HLA-Cw6 status The HLA-Cw6 dilemma: is it really an outcome predictor in psoriasis patients under biologic therapy?.
- Subjects
INTERLEUKIN-23; TREATMENT effectiveness; PSORIATIC arthritis
- Publication
Dermatologic Therapy, 2022, Vol 35, Issue 10, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.15741